De novo mutation causing sporadic type 2A von Willebrancd's disease: report of three cases

Summary. Chemical mismatch detection has been used to screen selectively part of the A2 domain of exon 28 of the von Willebrand factor gene of three unrelated patients with apparently sporadic type 2A von Willebrand disease (vWD) and their parents and siblings. Mismatches have been defined by DNA sequencing and mutations authenticated by restriction enzyme analysis. While a mutation was identified in all three patients, no evidence of mutation could be found in their asymptomatic/un‐affected parents or siblings, proving the disease to be truly sporadic in these cases. Of these, two with severe clinical bleeding had a serine 743 to leucine substitution while the third patient with clinically less severe bleeding had an arginine 834 to tryptophan substitution. The possible genetic mechanisms for sporadic type 2A vWD in these families are discussed.

[1]  T. Matsushita,et al.  Molecular Mechanism and Classification of von Willebrand Disease , 1995, Thrombosis and Haemostasis.

[2]  P. Mannucci,et al.  Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method , 1993 .

[3]  H. Koyama,et al.  Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. , 1993, Blood.

[4]  P. Mannucci,et al.  Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method. , 1993, Blood.

[5]  J. Lavergne,et al.  Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  Pille Harrison,et al.  Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families , 1992, Thrombosis and Haemostasis.

[7]  H. Saito,et al.  Three Distinct Candidate Point Mutations of the von Willebrand Factor Gene in Four Patients with Type IIA von Willebrand Disease , 1992, Thrombosis and Haemostasis.

[8]  D. Ginsburg,et al.  Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. , 1992, The Journal of biological chemistry.

[9]  A. Giles,et al.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease. , 1992, American journal of human genetics.

[10]  Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Ware,et al.  Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J M Sorace,et al.  Structure of the gene for human von Willebrand factor. , 1989, The Journal of biological chemistry.

[13]  D. Bentley,et al.  Direct detection of point mutations by mismatch analysis: application to haemophilia B. , 1989, Nucleic acids research.

[14]  D. Ginsburg,et al.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Prowse,et al.  Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis , 1987, Thrombosis and Haemostasis.

[16]  E. Tuddenham,et al.  A Two-Site, Monoclonal Antibody-Based Immunoassay for von Willebrand Factor -Demonstration that vWF Function Resides in a Conformational Epitope , 1986, Thrombosis and Haemostasis.

[17]  D. Barker,et al.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA , 1984, Cell.

[18]  F. Hill,et al.  Factor VIII related antigen: an improved enzyme immunoassay. , 1982, Medical laboratory sciences.